Vivian Corporation together with Roche Diagnostics gathered local and foreign Diabetes Care experts to exchange knowledge on creating awareness and improving diabetes management on the occasion of World Diabetes Day celebrated on 14th November.  

A number of local healthcare professionals involved in Diabetes Care were trained earlier this week by experts from Roche on the new Accu-Chek Aviva Expert. It is an innovative, clinically-proven blood glucose monitoring system that supports diabetes self-management of MDI (multiple daily injection or intensified insulin-treated patients). Accu-Chek Aviva Expert offers the embedded proven bolus advise for easy and reliable bolus calculation.  

According to the latest therapy guidelines, for optimal diabetes management, patients and physicians alike are highly dependent on accurate and detailed information. The evaluation of individual glucose profiles, and in particular of post-meal values, has shown to be important in determining therapeutic adjustments, since postprandial hyperglycaemia can be an independent cardiovascular risk factor.  In addition, latest study results have shown the automated Bolus Advisor to safely improve glycemic control with increased time within target range123, while at the same time not increasing hypoglycemia and reducing the participants’ fear of hypoglycemia. This in turn resulted not only in improved therapy outcomes but also in increased patients’ confidence in bolus administration and therapy satisfaction4. 

Vivian Corporation and Roche are sponsors of a number of World Diabetes Day campaigns and initiatives in Malta & Gozo. For further information patients are requested to speak to their diabetologist. More information is available at Vivian Corporation T: 2132 0338 E: [email protected] W: www.viviancorp.com